{"database": "lobbying", "table": "lobbying_activities", "rows": [[2787576, "7da19b37-e3e0-4e4e-bf99-c95403e38885", "Q1", "ASSOCIATION FOR CLINICAL ONCOLOGY", 401105592, "ASSOCIATION FOR CLINICAL ONCOLOGY", 2022, "first_quarter", "HCR", "S 464/HR 2163 Safe Step Act - implementing safe guards around step therapy (fail first) programs in ERISA regulated plans HR 1550 - PREVENT HPV Cancers Act of 2021 HR 3258 - TACT Act of 2021- improve patient access to anti-cancer oral medications S 610/HR 1667- Dr. Lorna Breen Health Care Provider Protection Act- address behavioral health and well-being among health care professionals HR 4385/S 3080- Cancer Drug Parity Act of 2021- oral parity HR 5801- HELP Copays Act- copay accumulator programs S 3039/HR 2503- Social Determinants Accelerator Act of 2021- SDOH HR 5030/S 2706- DIVERSE Trials Act- access to clinical trials HR 6584- DEPICT Act- access to clinical trials HR 6000- Cures 2.0 ARPA-H FDA User Fee Agreement Reauthorization", "HOUSE OF REPRESENTATIVES,SENATE", null, 213980, 0, 0, "2022-04-19T16:58:57-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2787576"], "units": {}, "query_ms": 0.3211640287190676, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}